Semaglutide: A Promising Ally Against Alzheimer’s?
In a groundbreaking study, researchers at Case Western Reserve School of Medicine have identified a potential new benefit of semaglutide, a widely used diabetes and weight-loss drug. According to their findings, semaglutide may significantly reduce the risk of Alzheimer’s disease in individuals with type 2 diabetes (T2D), outperforming seven other anti-diabetic medications.
Alzheimer’s disease, a devastating brain disorder that erodes memory and cognitive abilities, affects nearly 7 million Americans aged 65 and older, as reported by the Alzheimer’s Association. Alarmingly, it claims more lives annually than breast and prostate cancer combined.
Published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, the study suggests that T2D patients taking semaglutide had a markedly lower risk of developing Alzheimer’s disease. This trend was consistent across various subgroups, regardless of obesity status, gender, or age.
Semaglutide, a glucagon-like peptide receptor (GLP-1R) agonist, is the active ingredient in popular medications like Wegovy and Ozempic. It works by reducing hunger and regulating blood sugar levels in T2D patients.
Under the leadership of Rong Xu, a professor of biomedical informatics, the research team analyzed three years of electronic health records from nearly one million U.S. patients with T2D. Their statistical approach, which mimicked a randomized clinical trial, revealed that patients prescribed semaglutide had a significantly lower risk of Alzheimer’s compared to those on other anti-diabetic medications.
According to the CDC, Alzheimer’s disease results in approximately 120,000 deaths annually, ranking as the seventh-leading cause of death in the United States.
“This new study provides real-world evidence for semaglutide’s potential impact on Alzheimer’s disease,” Xu stated. “While preclinical research has hinted at its protective effects against neurodegeneration and neuroinflammation, our findings suggest the need for further exploration through randomized clinical trials.”
Despite these promising results, the study’s limitations prevent researchers from drawing definitive causal conclusions. Xu emphasized the importance of continued research into semaglutide’s potential as a treatment for this debilitating condition, encouraging further investigation into alternative drugs.
For more information, please contact Patty Zamora at [email protected].
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Florida homeowners — especially in hard‑hit South Florida — are set to see rare and substantial reductions in their property insurance premiums. Gov. Ron DeSantis announced an average statewide Citizens Insurance decrease of 8.7%, with even larger savings of up to 14% in counties like Miami-Dade, Broward, and Palm Beach. State officials credit recent legal and regulatory reforms for stabilizing the market, attracting new insurers, and delivering the first meaningful rate relief Floridians have seen in years.
Tampa’s commercial real estate market isn’t slowing—it’s maturing. With strong population growth, rising office demand, a normalized industrial sector, resurgent retail, and an emerging health‑care real estate boom, investors are shifting from speed to strategy. Tighter underwriting, cautious capital and increased due‑diligence are shaping a more disciplined market, creating new opportunities for informed professionals.
Florida homeowners are finally seeing relief as Citizens Property Insurance announces a major 8.7% average rate decrease—far larger than originally proposed. Driven by legislative reforms, fewer lawsuits, and a calm hurricane season, the state’s once‑unstable insurance market is showing real signs of recovery. But with reduced coverage limits and shifting legal protections, experts warn that lower premiums may come with hidden trade‑offs.
After a decade of rising premiums and retreating carriers, Florida homeowners are finally seeing long‑awaited relief. Dozens of insurers have filed for rate decreases—some as high as 11%—thanks to legislative reforms and a stabilizing market. Early approvals are already hitting counties across the state, and experts say the momentum could boost buyer confidence, affordability, and competition throughout Florida’s real estate and insurance sectors.
After years of slowed activity caused by rising interest rates, the self‑storage industry is heating up again. New data from Marcus & Millichap shows a fresh market cycle emerging, driven by renewed buyer confidence, recalibrated pricing, and stronger lender participation. Acquisitions are rebounding, development is resetting in a healthier direction, and financing conditions are improving—creating one of the most promising investment landscapes the sector has seen in years.
Brookline’s newly updated FEMA flood maps identify 97 high‑risk parcels, but local experts warn the true threat is far greater. While FEMA highlights river‑based flooding around Leverett Pond and the Muddy River, alternative models show more than 1,300 Brookline properties at risk within 30 years. Hidden vulnerabilities along major corridors like Beacon Street, rising rainfall intensity, aging infrastructure, and climate‑driven storm patterns suggest that many “low‑risk” areas may be anything but safe.
